Počet záznamov: 1
cyklofosfamid
SYS d003520 LBL 00000nz--a2200000o--4500 005 20250606213421.0 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.455.526.728.650.730.243 065 $a D02.705.672.500.243 066 $a 01 $c 03 150 $a cyklofosfamid $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d007166 $Y Immunosuppressive Agents $w P $a imunosupresíva 550 $7 sllk_us_auth*d009153 $Y Mutagens $w P $a mutagény 550 $7 sllk_us_auth*d018501 $Y Antirheumatic Agents $w P $a antireumatiká 550 $7 sllk_us_auth*d018906 $Y Antineoplastic Agents, Alkylating $w P $a antineoplastiká alkylačné 550 $7 sllk_us_auth*d019653 $Y Myeloablative Agonists $w P $a agonisty myeloablácie 680 9-
$i Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. $2 eng 750 -2
$a Cyclophosphamide $2 eng 980 $x M
Počet záznamov: 1